163 related articles for article (PubMed ID: 9558280)
1. Bismuth subsalicylate markedly decreases hydrogen sulfide release in the human colon.
Suarez FL; Furne JK; Springfield J; Levitt MD
Gastroenterology; 1998 May; 114(5):923-9. PubMed ID: 9558280
[TBL] [Abstract][Full Text] [Related]
2. Binding of hydrogen sulfide by bismuth does not prevent dextran sulfate-induced colitis in rats.
Furne JK; Suarez FL; Ewing SL; Springfield J; Levitt MD
Dig Dis Sci; 2000 Jul; 45(7):1439-43. PubMed ID: 10961726
[TBL] [Abstract][Full Text] [Related]
3. Physiology of sulfide in the rat colon: use of bismuth to assess colonic sulfide production.
Levitt MD; Springfield J; Furne J; Koenig T; Suarez FL
J Appl Physiol (1985); 2002 Apr; 92(4):1655-60. PubMed ID: 11896034
[TBL] [Abstract][Full Text] [Related]
4. Fecal hydrogen sulfide production in ulcerative colitis.
Levine J; Ellis CJ; Furne JK; Springfield J; Levitt MD
Am J Gastroenterol; 1998 Jan; 93(1):83-7. PubMed ID: 9448181
[TBL] [Abstract][Full Text] [Related]
5. Mitigation of in vitro hydrogen sulfide production using bismuth subsalicylate with and without monensin in beef feedlot diets.
Ruiz-Moreno M; Binversie E; Fessenden SW; Stern MD
J Anim Sci; 2015 Nov; 93(11):5346-54. PubMed ID: 26641054
[TBL] [Abstract][Full Text] [Related]
6. Reduced tetracycline bioavailability caused by magnesium aluminum silicate in liquid formulations of bismuth subsalicylate.
Healy DP; Dansereau RJ; Dunn AB; Clendening CE; Mounts AW; Deepe GS
Ann Pharmacother; 1997 Dec; 31(12):1460-4. PubMed ID: 9416381
[TBL] [Abstract][Full Text] [Related]
7. Cytoprotective effect of bismuth subsalicylate in indomethacin-treated rats is associated with enhanced mucus bismuth concentration.
Tanaka S; Guth PH; Carryl OR; Kaunitz JD
Aliment Pharmacol Ther; 1997 Jun; 11(3):605-12. PubMed ID: 9218090
[TBL] [Abstract][Full Text] [Related]
8. The effects of bismuth, iron, zinc and nitrate on free sulfide in batch cultures seeded with fecal flora.
Mitsui T; Edmond LM; Magee EA; Cummings JH
Clin Chim Acta; 2003 Sep; 335(1-2):131-5. PubMed ID: 12927694
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of effects of ethyl alcohol and bismuth subsalicylate on gastric mucosal barrier in man.
Dy RM; Lof J; DiBaise JK; Quigley EM
Dig Dis Sci; 1999 Feb; 44(2):286-9. PubMed ID: 10063913
[TBL] [Abstract][Full Text] [Related]
10. Site of bismuth absorption from bismuth subsalicylate: implications for treatment of colonic conditions.
Suarez FL; Furne J; Stiehm J; Garten C; Levitt MD
Dig Dis Sci; 2000 Jul; 45(7):1444-6. PubMed ID: 10961727
[TBL] [Abstract][Full Text] [Related]
11. Sulfate-reducing bacteria slow intestinal transit in a bismuth-reversible fashion in mice.
Ritz NL; Lin DM; Wilson MR; Barton LL; Lin HC
Neurogastroenterol Motil; 2017 Jan; 29(1):. PubMed ID: 27477318
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo effects of three bismuth compounds on fermentation by colonic bacteria.
León-Barúa R; Tello R; Morante MC; Alvarez M; Gilman RH; Spira WM
Rev Infect Dis; 1990; 12 Suppl 1():S24-9. PubMed ID: 2305175
[TBL] [Abstract][Full Text] [Related]
13. The effect of antibiotics and bismuth on fecal hydrogen sulfide and sulfate-reducing bacteria in the rat.
Ohge H; Furne JK; Springfield J; Sueda T; Madoff RD; Levitt MD
FEMS Microbiol Lett; 2003 Nov; 228(1):137-42. PubMed ID: 14612249
[TBL] [Abstract][Full Text] [Related]
14. Effect of bismuth subsalicylate on fecal microflora.
Gorbach SL; Cornick NA; Silva M
Rev Infect Dis; 1990; 12 Suppl 1():S21-3. PubMed ID: 2305174
[TBL] [Abstract][Full Text] [Related]
15. Stress, diet and alcohol-induced oxidative gastrointestinal mucosal injury in rats and protection by bismuth subsalicylate.
Bagchi D; Carryl OR; Tran MX; Krohn RL; Bagchi DJ; Garg A; Bagchi M; Mitra S; Stohs SJ
J Appl Toxicol; 1998; 18(1):3-13. PubMed ID: 9526828
[TBL] [Abstract][Full Text] [Related]
16. Effect of bismuth subsalicylate on ciprofloxacin bioavailability.
Rambout L; Sahai J; Gallicano K; Oliveras L; Garber G
Antimicrob Agents Chemother; 1994 Sep; 38(9):2187-90. PubMed ID: 7811043
[TBL] [Abstract][Full Text] [Related]
17. Influence of subsalicylate bismuth on absorption of doxycycline.
Ericsson CD; Feldman S; Pickering LK; Cleary TG
JAMA; 1982 Apr; 247(16):2266-7. PubMed ID: 7040708
[TBL] [Abstract][Full Text] [Related]
18. Hydrogen sulfide and colonic epithelial metabolism: implications for ulcerative colitis.
Jørgensen J; Mortensen PB
Dig Dis Sci; 2001 Aug; 46(8):1722-32. PubMed ID: 11508674
[TBL] [Abstract][Full Text] [Related]
19. Rectal bismuth subsalicylate as therapy for ulcerative colitis.
Ryder SD; Walker RJ; Jones H; Rhodes JM
Aliment Pharmacol Ther; 1990 Aug; 4(4):333-8. PubMed ID: 2103753
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activity of bismuth subsalicylate on Clostridium difficile, Escherichia coli O157:H7, norovirus, and other common enteric pathogens.
Pitz AM; Park GW; Lee D; Boissy YL; Vinjé J
Gut Microbes; 2015; 6(2):93-100. PubMed ID: 25901890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
